
Loading, please wait...

Loading, please wait...

Recent scientific findings highlight the therapeutic potential of green tea kombucha periodontitis management. Periodontitis remains a major oral health concern in India, often leading to significant bone loss if left untreated. This new study explored how fermentation duration affects the microbial composition and anti-inflammatory properties of green tea kombucha. Specifically, researchers investigated its impact on alveolar bone loss using a rat model. The results suggest that the duration of fermentation is a critical factor for success.
Researchers used metagenomic sequencing to analyze the microbial diversity within the fermented beverage. They discovered that kombucha fermented for four days contains a high abundance of the Acetobacteraceae and Saccharomycetaceae families. Furthermore, this specific fermentation time yielded the most significant clinical benefits. For instance, animals treated with four-day kombucha showed a 42.9% reduction in tumor necrosis factor-alpha. Consequently, this reduction directly influenced the severity of periodontal inflammation.
In addition to reducing inflammation, the four-day ferment significantly limited alveolar bone loss. Notably, researchers observed a 43.6% decrease in the receptor activator of nuclear factor kappa-B. Moreover, the expression of osteoprotegerin increased by approximately 55.4% in the treated tissues. Because these markers regulate bone remodeling, their modulation represents a powerful mechanism for oral health preservation. Most importantly, the study confirmed that kombucha did not cause any hepatic or renal toxicity.
Kombucha offers a safe and accessible probiotic option for supporting periodontal therapy. However, clinicians should remember that these results currently rely on animal studies. Therefore, further human clinical trials are necessary to validate these effects in patients. Regardless, the evidence supports the use of short-fermented kombucha as a promising adjunctive treatment. This approach could potentially enhance traditional scaling and root planing procedures.
Fermentation time changes the microbial and chemical profile of the drink. This study found that a 4-day fermentation period is superior for reducing inflammation and bone loss compared to longer durations.
Yes, the study indicated no systemic toxicity in the liver or kidneys, regardless of the fermentation time. Consequently, it appears safe for daily consumption in this context.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.
References
da Silva EC et al. Fermentation time Determines Anti-inflammatory and Osteoprotective Activity of Green Tea Kombucha in a Rat Model of Experimental Periodontitis. Probiotics Antimicrob Proteins. 2026 Feb 09. doi: 10.1007/s12602-026-10937-8. PMID: 41656480.
Matsubara VH, et al. Probiotics as Adjuncts in Periodontal Therapy: A Systematic Review and Meta-Analysis. J Dent. 2016;52:1-11.
Karygianni L, et al. Natural Compounds from Probiotics and Their Role in Oral Health. Front Microbiol. 2020;11:2120.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A recent study suggests that green tea kombucha fermented for four days reduces periodontal inflammation and bone loss without systemic toxicity....
8 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today